These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 8407584)
1. Microbial glycosidation of some anthracycline antibiotics by an antibiotic-negative mutant of aclarubicin producer. Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1993 Aug; 46(8):1219-31. PubMed ID: 8407584 [TBL] [Abstract][Full Text] [Related]
2. New betaclamycin and aclarubicin analogs obtained by prolonged microbial conversion with an aclarubicin-negative mutant. Johdo O; Yoshioka T; Naganawa H; Takeuchi T; Yoshimoto A J Antibiot (Tokyo); 1996 Jul; 49(7):669-75. PubMed ID: 8784429 [TBL] [Abstract][Full Text] [Related]
3. A gene cluster from Streptomyces galilaeus involved in glycosylation of aclarubicin. Räty K; Kunnari T; Hakala J; Mäntsälä P; Ylihonko K Mol Gen Genet; 2000 Sep; 264(1-2):164-72. PubMed ID: 11016846 [TBL] [Abstract][Full Text] [Related]
4. New anthracycline metabolites from mutant strains of Streptomyces galilaeus MA144-M1. I. Isolation and characterization of various blocked mutants. Yoshimoto A; Matsuzawa Y; Oki T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1981 Aug; 34(8):951-8. PubMed ID: 6947976 [TBL] [Abstract][Full Text] [Related]
5. Anthracycline metabolites from baumycin-producing Streptomyces sp. D788. I. Isolation of antibiotic-blocked mutants and their characterization. Yoshimoto A; Johdo O; Fujii S; Kubo K; Nishida H; Okamoto R; Takeuchi T J Antibiot (Tokyo); 1992 Aug; 45(8):1255-67. PubMed ID: 1399846 [TBL] [Abstract][Full Text] [Related]
6. Production of a new hybrid anthracycline 4-O-methylepelmycin by heterologous expression of dnrK in epelmycin-producing Streptomyces violaceus. Miyamoto Y; Ohta S; Johdo O; Nagamatsu Y; Yoshimoto A J Antibiot (Tokyo); 2000 Aug; 53(8):828-36. PubMed ID: 11079805 [TBL] [Abstract][Full Text] [Related]
7. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant. Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988 [TBL] [Abstract][Full Text] [Related]
8. Aclacinomycin X, a novel anthracycline antibiotic produced by Streptomyces galilaeus ATCC 31133. Kim HS; Kim YH; Yoo OJ; Lee JJ Biosci Biotechnol Biochem; 1996 May; 60(5):906-8. PubMed ID: 8704322 [TBL] [Abstract][Full Text] [Related]
9. Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730. Johdo O; Watanabe Y; Ishikura T; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1991 Oct; 44(10):1121-9. PubMed ID: 1955395 [TBL] [Abstract][Full Text] [Related]
10. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. II. Structure of new anthracycline antibiotics obtained by microbial glycosidation and biological activity. Matsuzawa Y; Yoshimoto A; Oki T; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Nov; 33(11):1341-7. PubMed ID: 6941953 [TBL] [Abstract][Full Text] [Related]
11. Biosynthesis of anthracycline antibiotics by Streptomyces galilaeus. I. Glycosidation of various anthracyclinones by an aclacinomycin-negative mutant and biosynthesis of aclacinomycins from aklavinone. Oki T; Yoshimoto A; Matsuzawa Y; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Nov; 33(11):1331-40. PubMed ID: 6941952 [TBL] [Abstract][Full Text] [Related]
12. Intensely potent anthracycline antibiotic oxaunomycin produced by a blocked mutant of the daunorubicin-producing microorganism. Yoshimoto A; Fujii S; Johdo O; Kubo K; Ishikura T; Naganawa H; Sawa T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1986 Jul; 39(7):902-9. PubMed ID: 3759649 [TBL] [Abstract][Full Text] [Related]
15. [New anthracycline antibiotics and derivatives]. Tatsuta K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977 [TBL] [Abstract][Full Text] [Related]
16. Production of new anthracycline antibiotics by microbial 4-O-methylation using a specific daunorubicin-negative mutant. Johdo O; Tone H; Okamoto R; Yoshimoto A; Takeuchi T J Antibiot (Tokyo); 1992 Dec; 45(12):1837-47. PubMed ID: 1490874 [TBL] [Abstract][Full Text] [Related]
17. Anthracycline metabolites from Streptomyces violaceus A262. IV. New anthracycline yellamycins produced by a variant strain SC-7. Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1991 Oct; 44(10):1155-9. PubMed ID: 1955397 [No Abstract] [Full Text] [Related]
18. Anthracycline metabolites from Streptomyces violaceus A262. V. New anthracycline alldimycin A: a minor component isolated from obelmycin beer. Johdo O; Tone H; Okamoto R; Yoshimoto A; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1991 Oct; 44(10):1160-4. PubMed ID: 1955398 [No Abstract] [Full Text] [Related]
19. Hybrid anthracycline antibiotics: production of new anthracyclines by cloned genes from Streptomyces purpurascens in Streptomyces galilaeus. Niemi J; Ylihonko K; Hakala J; Pärssinen R; Kopio A; Mäntsälä P Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1351-8. PubMed ID: 8081500 [TBL] [Abstract][Full Text] [Related]
20. Biotransformation of aklanonic acid by blocked mutants of anthracycline-producing strains of Streptomyces galilaeus and Streptomyces peucetius. Schumann G; Stengel C; Eckardt K; Ihn W J Basic Microbiol; 1986; 26(4):249-55. PubMed ID: 3464736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]